Watching David Graham, a reviewer in the FDA’s Office of Safety Research, give congressional testimony on CSPAN, it was clear that Dr. Graham is a man not to be messed with. He named the drugs he considers unsafe, detailing their effects. How can we have greater safety without lengthening an already difficult approval process? How should we treat new drugs? These are the questions we discuss.
